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ABSTRACT
Perturbation of gene expression by means of syn-
thetic small interfering RNAs (siRNAs) is a power-
ful way to uncover gene function. However, siRNA
technology suffers from sequence-specific off-target
effects and from limitations in knock-down effi-
ciency. In this study, we assess a further prob-
lem: unintended effects of siRNA transfections on
cellular fitness/proliferation. We show that the nu-
cleotide compositions of siRNAs at specific posi-
tions have reproducible growth-restricting effects
on mammalian cells in culture. This is likely dis-
tinct from hybridization-dependent off-target effects,
since each nucleotide residue is seen to be acting
independently and additively. The effect is robust
and reproducible across different siRNA libraries and
also across various cell lines, including human and
mouse cells. Analyzing the growth inhibition pat-
terns in correlation to the nucleotide sequence of
the siRNAs allowed us to build a predictor that can
estimate growth-restricting effects for any arbitrary
siRNA sequence. Competition experiments with co-
transfected siRNAs further suggest that the growth-
restricting effects might be linked to an oversatura-
tion of the cellular miRNA machinery, thus disrupting
endogenous miRNA functions at large. We caution
that competition between siRNA molecules could
complicate the interpretation of double-knockdown
or epistasis experiments, and potential interactions
with endogenous miRNAs can be a factor when as-
saying cell growth or viability phenotypes.
INTRODUCTION
Despite immense progress in gene editing technologies such
as CRISPR/Cas9 (1,2), transient siRNA transfection re-
mains a powerful technique for perturbing gene function
in the lab. The siRNAs (short interfering RNAs) bind tar-
get mRNAs via sequence complementarity, and interfere
post-transcriptionally with gene expression by inducing
mRNA degradation and/or by blocking translation (3–
5). The siRNA technique has advantages particularly in
high-content settings, where phenotypes can be analyzed
in high-throughput manner using automated microscopy
at sub-cellular resolution level (5,6) or in settings where a
complete removal of a gene’s function may be undesirable
due to lethality. siRNA interference has yielded critical in-
sights into the genetic foundations of a large number of
phenotypes, from cancer (7–12) to development (13–15) to
pathogen infections (16–21).
To achieve delivery of siRNAs into the cell, a num-
ber of approaches have been established, including expres-
sion from within the genome as short hair-pin precursor
molecules (shRNA), or transfection of synthetic mixtures
of double-stranded RNA molecules derived from longer
precursors (esiRNA). However, the most widely used deliv-
ery approach relies on commercially available libraries con-
sisting of defined, double-stranded siRNA oligonucleotides
(oligos). These oligos are designed to uniquely bind to a sin-
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gle target mRNA transcript, are transfected individually or
in pools, and are available at a genome-wide scope.
Perhaps owing to its maturity and wide-spread adoption,
a number of critical issues with the siRNA technology have
been identified. First, the knock-down efficiency that can be
achieved is typically not 100%, and can vary from gene to
gene and from siRNA to siRNA. Secondly, many siRNA
oligos will bind not only to the intended target transcript,
but in addition also to a number of other, unrelated tran-
scripts via partial sequence complementarity. This leads to
so called ‘off-target’ effects, and is thought to be a conse-
quence of siRNA oligos entering the endogenous miRNA
pathway, where they function essentially as miRNAs with
a concomitant broader range of targets. Off-target effects
are highly reproducible, and their specificity is mostly deter-
mined by a short stretch of nucleotides within the siRNA
molecules (nucleotide positions 2–8, corresponding to the
‘seed’ region in normal miRNAs) (22–24). Depending on
the phenotypic consequences, seed-based off-target effects
can dominate over the intended on-target readouts, and
may limit the discovery power of any given screen (24,25).
In addition, practitioners of siRNA screening will often
observe that the siRNA transfections per se affect cellu-
lar fitness. At the time points that are typically chosen for
phenotypic readouts (i.e., usually a few days after transfec-
tion) the number of cells in transfected populations is of-
ten noticeably smaller than that in mock-transfected pop-
ulations, even for non-targeting, ‘negative-control’ oligos.
The underlying mechanisms are still not entirely resolved.
RNAi mediated reductions in cellular fitness/proliferation
have been hypothesized to be due either to innate immu-
nity mechanisms responding to the presence of exogenous
RNA molecules (26–28), or to competitive interactions of
the siRNA molecules with endogenous RNAs, for example
with miRNAs that might be displaced from the endogenous
miRNA machinery (29–31).
For the present study, we have carefully analyzed
determinants of cellular fitness/proliferation in relation
to the oligonucleotide sequences, across a number of
screens conducted by different laboratories using differ-
ent commercial siRNA libraries. We uncovered consistent
fitness/proliferation effects of transfected siRNA oligos,
independent of their intended on-target activity. We find
that in part, these effects can be attributed to previously
described, seed-dependent off-target effects. However, we
find an additional, novel determinant, which is not a func-
tion of extended nucleotide sequence context as would be
expected for any hybridization-dependent mechanism. In-
stead, individual nucleotides within the oligos have inde-
pendent, additive and position-specific effects on cellular
growth/survival, and this can be modeled with simple lin-
ear regression. We hypothesize that this observation might
be due to competition between external and endogenous
RNAmolecules for some endogenous cellular binding part-
ner. We can indeed reproduce such a competition among
oligos in specific co-titration experiments. The strength of
this competition appears to be mostly a function of local
sequence composition, allowing us to create a generalized
software predictor for ‘cellular fitness/proliferation’ conse-
quences upon transfection of any given siRNA oligo se-
quence.
MATERIALS AND METHODS
Data sets
The present study is based on a number of large-scale
siRNA screens, whichwere originally carried out in the con-
text of a comparative project on host-pathogen interactions
(24,32). If not stated otherwise, here we are concerned not
with their infection readouts, but with the readouts in terms
of the number of cells after each perturbation. The pres-
ence of the pathogens did not influence the cell numbers in
a systematic way (data not shown), and our observations
were reproducible across all the distinct pathogens stud-
ied (four viruses, five bacteria). The image processing and
data normalization of the screens have been described pre-
viously (24,32). The final cell-number phenotypes were ex-
pressed as z-scores relative to the screening background of
each dataset. All processed and normalized, oligo-resolved
phenotypes are available as Supplementary Data Files ac-
companying themanuscript, together with siRNA sequence
information (to the extent permitted by the commercial li-
brary providers).
Cell number predictors
The siRNA nucleotide compositional profiles seen in Fig-
ure 2 were obtained by aggregating, for each datapoint, all
those siRNAs that happened to have a specific nucleotide at
one specific position (typically resulting in several thousand
oligos per datapoint). This was carried out for each of the
four nucleotides and over the entire range of possible posi-
tions of siRNAs, and the average phenotype of each group
was plotted. These positional profiles were then compared
to each other for different cell lines, vendors, organisms, and
phenotypes analyzed here, and their distances were visual-
ized in a PCoA plot.
A predictor for relative cell number, given an arbitrary
siRNA sequence, was constructed separately for each or-
ganism and library type. The predictor uses amultiple linear
regression model, with learned weights for each position.
Separately, a model was trained based on seed sequences
only––for this, not the individual nucleotide positions, but
the entire 7-mer sequences covering oligo-positions 2–8
constituted the data points. Both predictors were then com-
bined in a weighted linear fashion; the best performance
was seen at 50% relative weight for both (Figure 4).
Model validation using custom-designed siRNAs
Specific siRNA oligos were designed such that each had a
previously unobserved sequence, and no intended on-target
gene in the genome. Their nucleotide sequences were arbi-
trarily specified, sampling for each position a nucleotide ac-
cording to the position-specific weights of the linear regres-
sionmodel, aiming to design oligos of three classes: either to
reduce cell counts (‘growth-restricting’), to leave cell counts
unaffected (‘non-growth-restricting’), or to be representing
the background frequencies (‘randomly sampled’) of nu-
cleotides in the entire siRNA library (i.e. randomly sampled
controls). All of these designed customized sequences were
ordered fromQiagen using their HP custom siRNA synthe-
sis option.
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Human cervix carcinoma HeLa CCL2 cells (ATCC),
human airway epithelial A549 cells, and human diploid
WI38 fibroblasts were grown in Dulbecco Modified Eagle
Medium (DMEM, Sigma) supplemented with 10% heat in-
activated Fetal Calf Serum (FCS–– Invitrogen) at 37◦C and
5% CO2 and 95% humidity. All transfection experiments
were carried out in a 384-well plate format using a proto-
col for reverse transfection, cell fixation, staining, and imag-
ing as described in (32). Cell numbers used here were 700
cells/well (A549, HeLa CCL2 ATCC) or 1000 cells/well
(WI38). Cells were stained with DAPI and their microscopy
images were analysed with Cell Profiler (33) using a custom-
made pipeline allowing the detection of nuclei. Nucleus ob-
jects labelled ‘Nuclei’ were segmented in the DAPI chan-
nel using OTSU’s method (Cell Profiler module IdentifyPri-
mAutomatic), and counted to establish reliable cell counts.
Oligo-oligo competition assays
HeLa CCL2 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma) supplemented with 10%
heat inactivated fetal bovine serum (FBS, Gibco). siRNAs
were spotted in a random array into 384-well Clear Plates
(Greiner). Wells were loaded with 1.6 pmol of customized
siRNAs and with variable amounts of siRNA targeting the
KIF11 transcript (2-fold dilution series: range 9.77× 10−5–
25.6 pmol) in a final volume of 5 l of RNAse-free ddH2O
(Ambion).
For transfection, spotted siRNAs were complexed in
25 l of DMEM supplemented with 1:250 Lipofectamine
RNAiMAX (Invitrogen) at room temperature for 1 h.
Subsequently, 600 cells/well were seeded in 50 l of
DMEM/16% FCS to result in 10% FCS concentration. Fi-
nal siRNA concentrations were 20 nM for custom siRNAs
combined with diverse concentrations of siRNA targeting
KIF11 (1.95 × 10−5 M up to 5.12 M) as indicated in
Figure 5. Cells were incubated at 37◦C and 5% CO2 for
72 h. Cells were then fixed in 3.7% PFA/HEPES (Sigma,
PanReac AppliChem) for 10 min and were permeabilized
by 0.1% Triton X-100 (Sigma) in PBS for 10 min. DNA
was stained by 1 g/ml DAPI (Roche) in PBS. Imaging and
analysis: per condition nine images were acquired at an Im-
ageXpress system (Molecular Devices) with a 10× S Fluor
objective (Nikon). Images were analysed with the screening-
Bee analysis framework (https://www.screeningbee.org). To
correct for uneven illumination from widefield microscopy
imaging, the model for CIDRE illumination correction was
computed from all images (34). To ensure that CIDRE-
corrected image intensities fall within the [0.0, 1.0] range,
a linear intensity transformation for pixel intensities was
computed that maps the 0.001-quantile to 0.01 and the
0.999-quantile to 0.99 after illumination correction. On
illumination-corrected DAPI images, Cell Profiler 1 (33)
was executed to perform object segmentation and measure-
ments: nuclei were identified using ‘OTSUGlobal’ segmen-
tation. The median OTSU value was manually set as seg-
mentation threshold for the images.
Data from the co-transfection competition experiment
as seen in Figure 5 was analysed using the R-package drc
(35). The data was subjected to non-linear regression analy-
sis and fitted using the four-parameter log-logistic equation
shown below to determine at what concentration the siRNA
targeting the KIF11 transcript caused the reduction in cell
count by 50%, represented by the parameter e of the equa-
tion.
f (x, (b, c, d, e)) = c + d − c
1 + eb log xe
The four parameters in the equation are, c and d: coef-
ficients corresponding to the lower and upper asymptotes,
b: the slope of the line, and e: the response at the inflec-
tion point halfway between the upper and lower asymp-
totes (also known asED50). The inflection points computed
above for siRNAs targeting KIF11 transcript with or with-
out the presence of several customized siRNAs were sub-
jected to ANOVA to determine whether there were any sig-
nificant differences between them. This was then followed
by Tukey HSD analysis to determine the pairwise signifi-
cant difference between the inflection points at  = 0.05 in
different scenarios as seen in Figure 5.
AGO2 rescue assays
Analogous to the oligo–oligo competition assays, 1.6 pmol
of customized siRNAs loaded per 384-well-slot were com-
plexed. HeLa CCL-2 cells with a prior exposure of 48 h to
the following treatments (siAGO2, siGFP Duplex III, un-
treated) were seeded onto these complexed oligos to result
in a final custom oligo concentration of 20 nM per well.
Cells were incubated for 72 h and thereafter processed and
analysed for cell numbers. Ago2 knockdown quality after
single knockdown (Supplementary Figure S2A) and con-
secutive double knockdowns (Supplementary Figure S2B)
was assessed on Western blot (AGO2: Novus Biologicals
H00027161-M01, GAPDH: EMDMillipore ABS16).
RT-qPCR measurements to quantify interferon response
genes
To measure the levels of Human MX1, IFIT1, ISG15 and
OSA1, HeLa CCL-2 cells were reverse-transfected in 6-
well plates with 20 nM siRNAs using 0.1% (v/v) Lipofec-
tamineRNAiMAX (Invitrogen), according to themanufac-
turer’s instructions. Transfection reactions were performed
in serum-free OptiMEM (Gibco). Total RNA from the
siRNA transfected cells was extracted using mirVana RNA
isolation kit (Ambion). Following on-columnDNase diges-
tion (Qiagen), 300 ng of total RNA was reverse-transcribed
using the ‘Transcriptor’ First Strand cDNA Synthesis Kit
(Roche) with anchored-oligo(dT)18 primers. RT-qPCR was
performed using Power SYBR Green Master mix (Applied
Biosystems). Reactions were analyzed by an ABI 7000 real-
time PCR machine using the following cycle conditions:
50◦C for 10 min, 95◦C for 10 min, followed by 40 cycles at
95◦C for 15 s and 60◦C for 1 minute. Relative mRNA lev-
els (2−Ct) were determined by comparing the PCR quan-
tification cycle (Cq, determined with the Software SDS
2.2.1) and normalized against the reference gene expression
TATA-Box Binding Protein (TBP), elongation factor 1 al-
pha (EEF1A1) and transferrin receptor protein 1 (TFRC).
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RESULTS
Non-specific effects of siRNA transfections
We analyzed raw data from several RNAi pathogen-entry
screens that had been based on commercially available, de-
convoluted siRNA libraries from different vendors, and
had been executed in HeLa CCL2 cells (24). Three of the
screens were genome-wide pathogen screens, carried out for
two bacterial species (Brucella abortus and Salmonella ty-
phimurium, see Supplement) and a virus (Uukuniemi virus
(36)). In addition, several screens with a more restricted set
of perturbed genes were also analyzed, which addressed the
‘kinome’ only, i.e. the complement of human kinases and as-
sociated proteins (32). These latter screens covered a larger
number of pathogens, and used a larger number of different
siRNAs per gene (from three different vendors). All screens
above had been scored for infection-phenotypes as well as
cell-number phenotypes. All post-processing, image analy-
sis and normalization was standardized, with final pheno-
types reported as z-scores relative to the entire screening
background (32).
The cell-number phenotype from a typical genome-wide
pathogen screen (Brucella abortus) follows an approxi-
mately normal distribution, with a slight excess of low-
cell-count phenotypes (Figure 1A). While there is good
technical reproducibility of the cell-count phenotype of a
given siRNA oligo, there is a relatively poor phenotypic
reproducibility across distinct siRNAs targeting the same
gene, indicating a relative lack of on-target signal across all
pathogens and all screens that were analyzed. This is ex-
emplified in Figure 1B where four data points, representing
four distinct siRNAs targeting the same gene, individually
produce reproducible phenotypes across two independent
screens but fail to agree on the actual phenotype of the gene
perturbation.Globally, this behavior is observed for all phe-
notypes and screens tested (24) (for Adenovirus: data not
shown).
siRNAs are known to be associated with different types
of off-target effects (37). One of them is widely known, and
occurs when siRNAs act like microRNAs by partially hy-
bridizing through their ‘seed region’ with multiple mRNAs
and thus affecting many off-target transcripts in addition
to their intended targets. This seed-mediated off-target ef-
fect also dominates the cell-count phenotype in all of our
analyzed screens. siRNAs sharing the same seed sequence
(i.e. positions 2 to 8 of the siRNA sequence) produce simi-
lar phenotypes and cluster together. This can be seen from
two exemplary seed clusters in Figure 1C, where one seed
group decreases the cell number and the other enhances it.
The siRNAs belonging to each of these clusters share no
significant sequence similarity outside the shared seed se-
quence. These seed-mediated off-target effects for cell num-
bers are highly reproducible across the screens, even when
screens were carried out independently in two different lab-
oratories and across different pathogens (24).
However, in our study we observed an additional source
of off-target phenotypes, namely that individual nucleotide
positions in the siRNAmolecules can have independent and
additive effects on the observed cell number in all genome-
and kinome-wide screens that we have analyzed. This has
not been described before, to the best of our knowledge, and
seems distinct from a seed-mediated off-target effect as dis-
cussed below.
The effect becomes statistically visible when analyzing an
entire screen: we observed that the average cell number phe-
notype within a genome-wide screen (∼69 000 siRNAs tar-
geting ∼18 000 genes) can be shifted significantly depend-
ing on the nucleotide present at a single residue position in
the siRNAs, irrespective of the remainder of the sequence
and irrespective of their intended targets (Figure 1D). For
example, all those siRNAs from the genome-wide screen
that happened to have an adenine at their 6th position to-
gether produce a shifted cell-count phenotype distribution,
i.e. shifted towards higher cell numbers, as compared to,
e.g. a guanine at 6th position, which shifts to a lower cell
number. This was detectable for nearly all of the possible
positions within siRNAs, but the magnitude and direction-
ality of the shift depended on the type of nucleotide and its
precise position within the siRNA.
Robust positional effect of nucleotide composition on cell
count
Investigating more into the bias caused by individual nu-
cleotides at specific position of siRNAs on the cell number
phenotype, a nucleotide positional profile of all the pheno-
typic consequences of individual residue choices in an aver-
age siRNA emerges (Figure 2A and B). This profile was ob-
tained by aggregating all siRNAs with a specific nucleotide
at a given position into one data point (the aggregation was
carried out for each of the four nucleotides and over the en-
tire range of possible positions on siRNAs).
Remarkably, the effect is seen only in the cell-number phe-
notype, but not in the infection (cell-entry) phenotypes: The
average cell number plotted against the positional siRNA
nucleotide composition shows distinct, reproducible fea-
tures (Figure 2A), whereas the same position profile applied
to the infection phenotype (Figure 2B) remains essentially
flat for all pathogen tested. This is of note for the general in-
fection screening setup as well, as it confirms that the base-
line infection efficiency is largely independent of the cell
numbers reached in the screens (this had been controlled for
in preparative cell titration experiments during assay devel-
opment).
For the cell number phenotype, we observed that guanine
nucleotides generally led to lower cell-numbers, but the ef-
fect is position-dependent and has reproducible exceptions
at certain positions (for example position 10 where guanine
residues actually resulted in increased cell numbers instead
(Figure 2A). Also, the amplitude of the effect is not uni-
form across the length of the siRNA molecule, with posi-
tions closer to the 5′-end of the active guide strand gener-
ally having a stronger effect. We constructed similar pro-
files for each screen analyzed, and confirmed them in sepa-
rate experiments in human lung epithelial A549 cells (data
not shown) as well as in murine primary embryonic fibrob-
lasts (Figure 2C). We observed that the profile is highly ro-
bust and reproducible not only across different pathogen
screens and laboratories, but also across different cell lines
and siRNA library types. This is evidenced by the clustering
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Figure 1. Different types of off-target effects of siRNAs in RNAi pathogen screens. (A) Cell number distribution from a genome-wide pathogen screen
(here, Brucella abortus). (B) On-target reproducibility of the cell-number phenotype. The four data points highlighted in black represent four distinct
siRNAs targeting the same gene, shown against the genome-wide reproducibility of identical oligos in distinct screens (gray scatter plot of 69,000 siRNAs
targeting the human genome, in two pathogen screens; Pathogen1: Brucella abortus and Pathogen 2: Uukuniemi virus). (C) Strong and consistent seed-
mediated off-target effects of siRNAs across RNAi screens. The two clusters represent two different seed sequences, one increasing the cell number and
the other decreasing it. All data points in each cluster represent oligos targeting different genes but containing the respective seed sequence of the cluster.
Background scatter as in (B). (D) Shifted cell-count distributions, caused by the presence of a single nucleotide at a specified position. Three different cell
count distributions are represented by three colored line types. The black solid line represents the cell count of all the siRNAs in a genome-wide screen
(Brucella abortus screen), pink dotted and violet dashed lines represent cell count distributions of all those siRNAs in that same screen that have either
adenine at 6th position or guanine at 6th position, respectively. In all panels, the box-plots denote the percentiles 25%, 50% and 75%, respectively, with
their whiskers extending to the highest or lowest data points that are at most 1.5 times the box distance away from the box.
of black data points in the summary panel 2D, each repre-
senting the siRNA nucleotide positional profile of the cell
number phenotype in a single screen. In contrast, the in-
fection phenotype never resulted in a reproducible pattern,
and the various screens were not clustered (light gray dots
in panel 2D).
Commercial siRNA libraries are not utilizing each nu-
cleotide at the same frequency; instead, they follow certain
general design principles (38–40), although the detailed de-
sign algorithms are typically kept proprietary.We compared
our observed position-dependent nucleotide profiles against
plots showing these inherent ‘design-biases’ for each library
(Supplementary Figure S3). We observe that the positional
nucleotide biases in the three libraries are distinct from our
phenotypic profiles described in Figure 2––the design bi-
ases affect different nucleotides at different positions (most
strongly positions #1, #10 and #19), and the biases are not
preferentially clustered towards the seed region. When in-
cluding the library design bias profiles in a direct compar-
ison with our phenotypic profiles, they clustered with each
other but clearly distant from the phenotype profiles (PCoA
plot in Supplementary Figure S2C, red dots). Design biases
are therefore unlikely to explain the phenotypic profiles.
Furthermore, it should be noted that our phenotype pro-
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Figure 2. Positional profiles of phenotypic consequences of individual nucleotides at individual siRNA positions. (A–C) Each data point represents the
average phenotype of all siRNAs that happen to have the specified nucleotide at that particular position. Note that the first position on the 5′-end is not
considered here, since it has a strong technical bias in library design and not all nucleotides are sufficiently covered there (see also Supplementary Figure
S2). (A, B) Positional profile for cell count and infection phenotypes, respectively, in a genome-wide Brucella abortus screen in HeLa CCL2 cells conducted
with a non-pooled siRNA library (Qiagen). (C) siRNA nucleotide positional profile for cell count in a genome-wide screen for Salmonella entry intoMEFs
(murine embryonic fibroblasts, unpublished). (D) Global comparison of siRNA nucleotide profiles, generated for three different pathogen screens (Brucella
abortus, Salmonella Typhimurium and Adenovirus), across three different libraries of non-pooled siRNAs designed by Qiagen, Dharmacon and Ambion
(QU, DU and AU, respectively) targeting human kinome genes (∼ 800) in HeLa CCL2 cells, together with another genome-wide screen carried out in
human A549 cells and mouse embryonic fibroblast cells using non-pooled Dharmacon (DU) and Qiagen libraries (QUM), respectively. Each data point
represents the entire nucleotide profile as seen in panels A–C. Black color denotes cell count readouts and gray color denotes infection readouts.
files were determined from subsets of siRNA oligos where a
given position of interest was ‘fixed’ for a given nucleotide
of interest (Figure 2A). With the exception of position #1,
which has the strongest design bias and is not considered
here, this means that several thousand oligos were available
for each nucleotide of interest at each position, allowing a
robust statistical inference.
Effective cell count prediction from a model based on siRNA
positional phenotype profiles
The reproducibility and robustness of the positional phe-
notype profile for cell counts made it seem possible to use it
for predicting the cell number computationally, given only
the siRNA sequence information. We set up a simple lin-
ear regression model, using 90% of the screening data for
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training and the rest (10%) for testing. This was done for
three genome-wide pathogen screens; using the model we
were able to predict the cell counts to around 55–60% accu-
racy in each of these screens (Figure 3A). In the next step,
we validated the model by experimentally testing custom-
ordered siRNA oligos with an arbitrary sequence, designed
on the basis of the profile (Figure 3B). These siRNAs were
non-targeting and not seen before in any of the libraries
used in the studies. We designed three kinds of customized
siRNAs according to the above model prediction. One class
was predicted to restrict the cell number, labelled as ‘growth
restricting’, the other was predicted to have minimal effect
on the cell number, labelled as ‘non-growth restricting’, and
the third class of ‘randomly sampled’ siRNAs was based on
the library-wide background frequencies of nucleotides at
each position. These oligos, together with appropriate con-
trols, were assembled in a 384-well plate format, and tested
in three human cell lines: HeLa, A549 and WI38 cells. In-
deed, our model successfully predicted the transfection out-
comes in terms of cell numbers, for extreme as well as for
intermediate phenotypes, suggesting that it can be used to
estimate phenotypes for oligos that have not been tested be-
fore.
Secondly, despite being trained onHeLaCCL2 cells only,
the model was able to predict cell counts not only in HeLa
cells (with up to 70% accuracy, Figure 3C) but also in A549
(cancerous cells; adenocarcinomic human alveolar basal ep-
ithelial cells) and WI38 (normal diploid fibroblasts derived
from lung tissue) cells to about 60% and 50% accuracy, re-
spectively (Figure 3D). This would hint at a commonmech-
anism behind this growth restricting effect in all these three
(different) cell lines.
Combined cell-count predictor using both seed-based and
nucleotide-based modeling
Next, our aim was to increase the power of our model by
combining it with the known ‘seed-based’ off-target effects
that also impact on cellular fitness/proliferation. Hence, the
second part of the model was based on learning the aver-
age seed phenotypes for each 7-mer seed sequence from the
screening data, unlike the first part, which was based on in-
dependent positional contribution of each of the four nu-
cleotides at each possible position.
We again used 90% of genome-wide screening data to
train the linear model and used the same data to extract an
average seed phenotype. These two factors where indepen-
dently used to predict the remaining 10% of data for both
infection and cell count phenotypes. Figure 4A shows that
the linear regressionmodel was able to predict the cell count
with up to 55% accuracy whereas it has again no predictive
power on the infection phenotype (Figure 4D). Contrary to
this, seed models could predict both cell count and infec-
tion phenotypes up to 55% and 54%, respectively (Figure
4B and E). One caveat of using seed models for prediction
purposes is the restricted availability of seed information in
the training data. Not all possible seed sequences are repre-
sented in genome-wide screens, which is also shown by the
vertical line at position zero in Figure 4B and E, reflecting
test oligos for which no prediction could be made.
We then combined these two models in an effort to en-
hance the overall prediction power for the cell-count. This
was done by averaging the prediction output from both
models in a weighted manner (Figure 4C). We observed
that the final model, at 50% contribution each from the
nucleotide composition model and the seed effect model
(Figure 4F), was able to increase the accuracy of the cell
count prediction from 55% (single models) to 65% (com-
bined model). This superior combined model relies on av-
erage seed phenotype information, which may not always
be available. In such cases, where a lack of seed representa-
tion in the library prevents a combined analysis, the linear
nucleotide composition model can still be used – it is appli-
cable to any oligo, and furthermore requires much less data
to train.
Growth-restricting effects of siRNA transfections may be due
to competition with endogenous processes
It has been shown in previous studies that transfected siR-
NAs can reduce the viability of cells due to a variety of unin-
tended effects, some of which are related to innate immune
responses and/or to possible saturation of the endogenous
RNAi machinery (27–29,31).
We experimentally investigated both these above scenar-
ios. First, we conducted a RT-qPCR experiment to detect
any upregulation of innate immune marker genes in re-
sponse to transfection with customized siRNAs. This was
done at two time points (12 h and 24 h post transfec-
tion) (Supplementary Figure S1). The RT-qPCR experi-
ments showed no significant immune response for any cus-
tomized siRNA at either exposure interval. Secondly, we
set up a competition experiment, by transfecting cells with
a standard siRNA having a known on-target effect, com-
bined with various test oligos of customized sequence. By
first establishing the dose-response curve for the known,
well characterized siRNA alone, we were then able to de-
tect any competitive influences of other co-transfected oli-
gos, via horizontal shifts in that dose-response curve. We
tested three kinds of potential competitor oligos, namely
those predicted by our algorithm to be fitness-reducing or
non-fitness-reducing, plus randomly sampled background
controls. All competitor oligos were applied as custom-
designed, arbitrary sequences, with no intended on-target.
This experimental competition setup (Figure 5A, B) in-
deed revealed a strong competitive interaction between the
various customized siRNAs and a known on-target siRNA
(the latter is designed to target the KIF11 transcript; KIF11
is essential for cell division and its knockdown leads to
strong cell death). Remarkably, co-transfected siRNAs can
shift the dose-response curve of the KIF11 oligo towards
higher viability (Figure 5A). This is particularly striking,
as the competitor siRNAs themselves had been selected
due to their capability to reduce cell numbers (i.e. cellu-
lar fitness/proliferation). In our view, this counter-intuitive
outcome can be explained only by competition, presum-
ably for some rate-limiting component of the RNAi ma-
chinery. The shift observed in Figure 5A is statistically sig-
nificant, and shows that a tenfold higher concentration of
KIF11 is required in order to inhibit cell growth in pres-
ence of a growth-restricting siRNA. This competition var-
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky798/5095462 by W
W
Z Bibliothek (O
effentliche Bibliothek der U
niversitÃ¤t Basel) user on 08 O
ctober 2018
8 Nucleic Acids Research, 2018
Figure 3. Predicting cell-number reductions from siRNA sequence. (A) A linear model was trained on 90% of the Uukuniemi genome-wide screening data
and used to predict the remaining 10% of data. Correlation plot between observed and predicted values for cell count upon transfection. (B) Experimental
design for testing the predictor with previously unobserved, arbitrary siRNA sequences. Oligos are separated by design-class, and observed phenotypes are
shown. (C) Correlation plot between observed and predicted values of customized siRNAs in HeLa CCL2 cells. (D) Experimentally validating the model
prediction across cell lines. The linear model trained on a genome-wide screen in HeLa CCL2 cells (Brucella abortus screen) was used to predict the cell
counts across different cell lines. Summary/correlation plots between the observed and predicted values of customized siRNAs across cell lines. The small
histograms in the center describe the distribution of data points along the x-axis, per column.
ied in a predictable manner with the various sequences of
co-transfected siRNAs (Figure 5B) as seen by the differ-
ent significant shifts in the concentration response curve
of siRNA targeting KIF11 (Figure 5B, C). The degree to
which a customized siRNAwas competingwas directly pro-
portional to its growth-restricting effect when applied alone,
whereby the most effective growth-restricting siRNAs were
also the strongest KIF11 competitors (Figure 5D).
The above observations lead us to hypothesize that the
different classes of competitor siRNAs have different bind-
ing preferences for one or several components of the RNAi
machinery, and hence can compete more or less efficiently
with other oligonucleotides binding to these components.
This would allow them to saturate the machinery to differ-
ent degrees as shown by the distinct shifts in concentration
response curves elicited by them.
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Figure 4. Combined modeling to increase the predictive power. (A, B) Performance of the two individual models for predicting the cell growth phenotype,
trained (A) on individual nucleotide positions, and (B) on 7-mer seed sequences at position 2–8. (D, E). Corresponding plots for the infection phenotype.
Plots show correlations between the observed and predicted phenotypes. (C) Combining seedmodel and linear nucleotide model predictions to find the best
possible combination of the two models for maximum prediction power. Each data point represents the correlation between the observed and combined
prediction from both models. The combined prediction is calculated by combining the prediction output from both models in different percentages (the
x-axis shows the weight percentage of the linear model). (F) Combined final model. Correlation plot between the observed and the combined prediction
from both models. The prediction output is a combination with 50% contribution from both models.
If correct, our hypothesis would predict that these com-
petitive effects between siRNAs should happen somewhere
along the miRNA processing pathway, at or upstream of
the RISC complex. We therefore tested the involvement of
Argonaute, the centralRISC component, by lowering active
Argonaute concentration through AGO2 siRNA knock-
downs (Supplementary Figure S2). First, we observed that
AGO2 knockdowns reduced cellular fitness/proliferation
already by themselves, without any further oligos added
(cell counts were reduced by roughly 20%, relative to GFP
control knockdowns). This is consistent with a central role
of AGO2, and the fact that AGO2 is essential, already for
early embryonic development (41). Next, we tested the ef-
fect of AGO2 reduction on the function of a given on-
target siRNA, using the strong KIF11 siRNA cell death
phenotype, as above. Remarkably, AGO2 knockdown leads
to a strong rescue of the KIF11 phenotype, rescuing cell
numbers from <200 to >900 (Supplementary Figure S2).
This indicates that the RISC complex is indeed function-
ally required for the action of siRNAs, at least with re-
spect to their on-target action. In a last step, we then
tested the effects of AGO2 knockdowns on several dozen
of our custom-designed competitor siRNAs (none of which
have any intended on-target). In the knockdown, the differ-
ence between strong and weak competitors, which normally
amounts to a cell number difference of more than 50%,
is strongly reduced, with a remaining difference of <20%.
Importantly, relative to a control knockdown using siGFP,
an AGO2 knockdown actually leads to enhanced cell num-
bers in the case of strong competitor oligos, amounting to a
rescue of ∼45% (Supplementary Figure S2, P = 5 · 10−8).
Together, these observations are consistent with a scenario
in which the competition takes place somewhere along the
miRNA processing pathway, a mechanism that presumably
can affect endogenous miRNAs similarly.
It has been observed in previous studies that changes in
the expression of endogenous miRNAs upon transfection
with certain siRNAs generally lead to noticeable changes
at genomic and proteomic levels (29–31). These might
then give rise to the sequence-dependent and predictable
cell-count phenotypes that we observe here, ranging from
strongly reduced cellular fitness/proliferation to hardly any
effect.
DISCUSSION
A full understanding of the unintended side-effects of
siRNA transfections is particularly important in the con-
text of therapeutic applications, or in quantitative genet-
ics experiments (e.g. double knockdowns in epistasis set-
tings). Those siRNA sequences that are particularly prob-
lematic for cellular fitness / proliferation, as predicted by
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Figure 5. Co-transfected siRNAs compete with one another in a predictable manner. (A) A titration experiment was set up to establish a dose-response
curve for a standard siRNA targeting the KIF11 transcript, which has a strong on-target effect (cell death) and is thus used as a transfection control in
many screens. (A, B) The black curve from (A) was repeated with various oligos co-transfected at a constant amount, and the horizontal shift of the dose-
response curve was measured. (C) Significance of shifts in concentration response curves upon co-transfecting various classes of siRNAs (in each pairing,
the left oligo was titrated, and the right was given at a constant amount; FC = fold change, dividing the right oligo’s inflection point by the left oligo’s
inflection point). (D) Correlation plot between shifts in concentration response curves of siRNAs targeting KIF11 upon co-transfection with customized
siRNAs, and decrease in cell number upon transfection with these customised oligos alone.
our model, could be avoided in such settings – or used
in lower dosage to reduce the observed effects. Our co-
transfection experiments suggest that competition between
co-transfected siRNAs may reduce the efficacy of any indi-
vidual siRNA in a given experiment, therefore the results of
double-knockdown epistasis perturbations need to be inter-
preted with caution.
How exactly the reduction in cellular fitness/proliferation
comes about mechanistically may be difficult to unravel:
first, the effect––albeit universally observed in all libraries
and cell lines that we tested––is relatively mild. After 72
hours of siRNA transfection, the strongest observed re-
duction in cell numbers is only ∼48%, with the overall
strength of the effect depending on the type of library and
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the transfection conditions. Second, it is conceivable that
the observed phenotype is the result of multiple mech-
anistic insults, brought about by several small changes
in endogenous miRNA efficiency followed by pleiotropic
downstream effects. Third, the effect can be easily masked
in any given oligo of interest, by the (stronger) impact
of seed-directed, hybridization-dependent off-target bind-
ing. Nevertheless, systematic measurements of endogenous,
target-bound miRNAs in the absence or presence of strong
‘fitness-reducing’ competitors may reveal sets of affected
miRNAs which can be followed up experimentally in the
future. It should be noted that the other, independent phe-
notype that was studied here (the infection phenotype) does
not show any discernible nucleotide-by-nucleotide effects
(Figure 2B). This might indicate that this phenotype is un-
der the control of a smaller number of genes; pathogens
might also have evolved to be robust against small pertur-
bations in the quantitative makeup of the host cell.
What does our observation imply for high-throughput
screening? At least for the human KIF11 gene, which we
tested here in detail, our dose-response curves suggest that
the oligo concentrations that are routinely used in high-
throughput screens are fairly high––certainly well into the
fully saturated regime. This may be problematic since any
excess amount of oligo is free to interfere with cellular
fitness/proliferation, but no longer increases the desired
knock-down effect on the target gene. There are several
strategies conceivable to improve the situation. One strat-
egy is to pool several distinct siRNAs for each intended tar-
get gene, either explicitly or by slicing up longer precursor
RNAs (e.g. esiRNAs/siPools) (42,43). This lowers the con-
centration of each individualmolecular species, andmay av-
erage out the competitive effects to some degree.
Alternatively, staying with individual siRNA species in
order to have better-defined perturbations, one might need
to lower the overall concentrations at which these oligos are
used in screens; this would require carefully titrating the in-
tended assays/readouts using applicable positive controls
(so as to avoid going too low). Perhaps more promising,
however, would be a two-fold approach: first, to avoid prob-
lematic sequences already at the library design stage as they
can now be fairly confidently predicted in silico, and second,
tomove away from uniform abundance distributions of siR-
NAs in libraries. After all, in many cases the expected rel-
ative concentrations of the intended target mRNAs in the
cell are well known or can be measured easily. Then, ad-
justing the stoichiometries of the siRNA molecules in the
libraries accordingly, would give a better overall fit between
the perturbing reagents and their targets. This would allow
the titration of the whole library––en bloc–– toward an op-
timal transfection condition for any given screen, balancing
knockdown efficiency versus non-specific side effects.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Swiss Confederacy (SystemsX.ch grants ‘InfectX’ and ‘Tar-
getInfectX’); Swiss National Science Foundation [31003A-
160095]. Funding for open access charges: University of
Zurich.
Conflict of interest statement.None declared.
REFERENCES
1. Sander,J.D. and Joung,J.K. (2014) CRISPR-Cas systems for editing,
regulating and targeting genomes. Nat. Biotechnol., 32, 347–355.
2. Taylor,J. and Woodcock,S. (2015) A perspective on the future of
High-Throughput RNAi screening: will CRISPR cut out the
competition or can RNAi help guide the way? J. Biomol. Screen., 20,
1040–1051.
3. Mello,C.C. and Conte,D. Jr (2004) Revealing the world of RNA
interference. Nature, 431, 338–342.
4. Meister,G. and Tuschl,T. (2004) Mechanisms of gene silencing by
double-stranded RNA. Nature, 431, 343–349.
5. Mohr,S.E., Smith,J.A., Shamu,C.E., Neumuller,R.A. and
Perrimon,N. (2014) RNAi screening comes of age: improved
techniques and complementary approaches. Nat. Rev. Mol. Cell Biol.,
15, 591–600.
6. Mattiazzi Usaj,M., Styles,E.B., Verster,A.J., Friesen,H., Boone,C.
and Andrews,B.J. (2016) High-content screening for quantitative cell
biology. Trends Cell Biol., 26, 598–611.
7. Zender,L., Xue,W., Zuber,J., Semighini,C.P., Krasnitz,A., Ma,B.,
Zender,P., Kubicka,S., Luk,J.M., Schirmacher,P. et al. (2008) An
oncogenomics-based in vivo RNAi screen identifies tumor
suppressors in liver cancer. Cell, 135, 852–864.
8. Luo,J., Emanuele,M.J., Li,D., Creighton,C.J., Schlabach,M.R.,
Westbrook,T.F., Wong,K.K. and Elledge,S.J. (2009) A genome-wide
RNAi screen identifies multiple synthetic lethal interactions with the
Ras oncogene. Cell, 137, 835–848.
9. Hubert,C.G., Bradley,R.K., Ding,Y., Toledo,C.M., Herman,J.,
Skutt-Kakaria,K., Girard,E.J., Davison,J., Berndt,J., Corrin,P. et al.
(2013) Genome-wide RNAi screens in human brain tumor isolates
reveal a novel viability requirement for PHF5A. Genes Dev., 27,
1032–1045.
10. Marcotte,R., Brown,K.R., Suarez,F., Sayad,A., Karamboulas,K.,
Krzyzanowski,P.M., Sircoulomb,F., Medrano,M., Fedyshyn,Y.,
Koh,J.L.Y. et al. (2012) Essential gene profiles in breast, pancreatic,
and ovarian cancer cells. Cancer Discov., 2, 172–189.
11. Luo,B., Cheung,H.W., Subramanian,A., Sharifnia,T., Okamoto,M.,
Yang,X., Hinkle,G., Boehm,J.S., Beroukhim,R., Weir,B.A. et al.
(2008) Highly parallel identification of essential genes in cancer cells.
Proc. Natl. Acad. Sci. U.S.A., 105, 20380–20385.
12. McDonald,E.R. 3rd, de Weck,A., Schlabach,M.R., Billy,E.,
Mavrakis,K.J., Hoffman,G.R., Belur,D., Castelletti,D., Frias,E.,
Gampa,K. et al. (2017) Project DRIVE: A compendium of cancer
dependencies and synthetic lethal relationships uncovered by
large-scale, deep RNAi screening. Cell, 170, 577–592.
13. Guo,B., Huang,X., Zhang,P., Qi,L., Liang,Q., Zhang,X., Huang,J.,
Fang,B., Hou,W., Han,J. et al. (2014) Genome-wide screen identifies
signaling pathways that regulate autophagy during Caenorhabditis
elegans development. EMBO Rep., 15, 705–713.
14. Mummery-Widmer,J.L., Yamazaki,M., Stoeger,T., Novatchkova,M.,
Bhalerao,S., Chen,D., Dietzl,G., Dickson,B.J. and Knoblich,J.A.
(2009) Genome-wide analysis of Notch signalling in Drosophila by
transgenic RNAi. Nature, 458, 987–992.
15. Ding,L., Paszkowski-Rogacz,M., Nitzsche,A., Slabicki,M.M.,
Heninger,A.K., de Vries,I., Kittler,R., Junqueira,M., Shevchenko,A.,
Schulz,H. et al. (2009) A genome-scale RNAi screen for Oct4
modulators defines a role of the Paf1 complex for embryonic stem cell
identity. Cell Stem Cell, 4, 403–415.
16. Karlas,A., Machuy,N., Shin,Y., Pleissner,K.P., Artarini,A., Heuer,D.,
Becker,D., Khalil,H., Ogilvie,L.A., Hess,S. et al. (2010)
Genome-wide RNAi screen identifies human host factors crucial for
influenza virus replication. Nature, 463, 818–822.
17. Panda,D. and Cherry,S. (2012) Cell-based genomic screening:
elucidating virus-host interactions. Curr. Opin. Virol., 2, 784–792.
18. Kuhbacher,A., Emmenlauer,M., Ramo,P., Kafai,N., Dehio,C.,
Cossart,P. and Pizarro-Cerda,J. (2015) Genome-Wide siRNA screen
identifies complementary signaling pathways involved in listeria
infection and reveals different actin nucleation mechanisms during
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky798/5095462 by W
W
Z Bibliothek (O
effentliche Bibliothek der U
niversitÃ¤t Basel) user on 08 O
ctober 2018
12 Nucleic Acids Research, 2018
listeria cell invasion and actin comet tail formation.MBio, 6,
e00598-15.
19. Andritschke,D., Dilling,S., Emmenlauer,M., Welz,T., Schmich,F.,
Misselwitz,B., Ramo,P., Rottner,K., Kerkhoff,E., Wada,T. et al.
(2016) A Genome-Wide siRNA screen implicates Spire1/2 in
SipA-Driven salmonella typhimurium host cell invasion. PLoS One,
11, e0161965.
20. Kreibich,S., Emmenlauer,M., Fredlund,J., Ramo,P., Munz,C.,
Dehio,C., Enninga,J. and Hardt,W.D. (2015) Autophagy proteins
promote repair of endosomal membranes damaged by the salmonella
type three secretion system 1. Cell Host Microbe, 18, 527–537.
21. Misselwitz,B., Dilling,S., Vonaesch,P., Sacher,R., Snijder,B.,
Schlumberger,M., Rout,S., Stark,M., von Mering,C., Pelkmans,L.
et al. (2011) RNAi screen of Salmonella invasion shows role of COPI
in membrane targeting of cholesterol and Cdc42.Mol. Syst. Biol., 7,
474.
22. Jackson,A.L., Burchard,J., Schelter,J., Chau,B.N., Cleary,M., Lim,L.
and Linsley,P.S. (2006) Widespread siRNA “off-target” transcript
silencing mediated by seed region sequence complementarity. RNA,
12, 1179–1187.
23. Lin,X., Ruan,X., Anderson,M.G., McDowell,J.A., Kroeger,P.E.,
Fesik,S.W. and Shen,Y. (2005) siRNA-mediated off-target gene
silencing triggered by a 7 nt complementation. Nucleic Acids Res., 33,
4527–4535.
24. Franceschini,A., Meier,R., Casanova,A., Kreibich,S., Daga,N.,
Andritschke,D., Dilling,S., Ramo,P., Emmenlauer,M., Kaufmann,A.
et al. (2014) Specific inhibition of diverse pathogens in human cells by
synthetic microRNA-like oligonucleotides inferred from RNAi
screens. Proc. Natl. Acad. Sci. U.S.A., 111, 4548–4553.
25. Singh,S., Wu,X., Ljosa,V., Bray,M.A., Piccioni,F., Root,D.E.,
Doench,J.G., Boehm,J.S. and Carpenter,A.E. (2015) Morphological
profiles of RNAi-Induced gene knockdown are highly reproducible
but dominated by seed effects. PLoS One, 10, e0131370.
26. Fedorov,Y., Anderson,E.M., Birmingham,A., Reynolds,A.,
Karpilow,J., Robinson,K., Leake,D., Marshall,W.S. and Khvorova,A.
(2006) Off-target effects by siRNA can induce toxic phenotype. RNA,
12, 1188–1196.
27. Judge,A.D., Sood,V., Shaw,J.R., Fang,D., McClintock,K. and
MacLachlan,I. (2005) Sequence-dependent stimulation of the
mammalian innate immune response by synthetic siRNA. Nat.
Biotechnol., 23, 457–462.
28. Reynolds,A., Anderson,E.M., Vermeulen,A., Fedorov,Y.,
Robinson,K., Leake,D., Karpilow,J., Marshall,W.S. and Khvorova,A.
(2006) Induction of the interferon response by siRNA is cell type- and
duplex length-dependent. RNA, 12, 988–993.
29. Liang,X.H., Hart,C.E. and Crooke,S.T. (2013) Transfection of
siRNAs can alter miRNA levels and trigger non-specific protein
degradation in mammalian cells. Biochim. Biophys. Acta, 1829,
455–468.
30. Castanotto,D., Sakurai,K., Lingeman,R., Li,H., Shively,L.,
Aagaard,L., Soifer,H., Gatignol,A., Riggs,A. and Rossi,J.J. (2007)
Combinatorial delivery of small interfering RNAs reduces RNAi
efficacy by selective incorporation into RISC. Nucleic Acids Res., 35,
5154–5164.
31. Khan,A.A., Betel,D., Miller,M.L., Sander,C., Leslie,C.S. and
Marks,D.S. (2009) Transfection of small RNAs globally perturbs gene
regulation by endogenous microRNAs. Nat. Biotechnol., 27, 549–555.
32. Ramo,P., Drewek,A., Arrieumerlou,C., Beerenwinkel,N.,
Ben-Tekaya,H., Cardel,B., Casanova,A., Conde-Alvarez,R.,
Cossart,P., Csucs,G. et al. (2014) Simultaneous analysis of large-scale
RNAi screens for pathogen entry. BMC Genomics, 15, 1162.
33. Carpenter,A.E., Jones,T.R., Lamprecht,M.R., Clarke,C., Kang,I.H.,
Friman,O., Guertin,D.A., Chang,J.H., Lindquist,R.A., Moffat,J.
et al. (2006) CellProfiler: image analysis software for identifying and
quantifying cell phenotypes. Genome Biol., 7, R100.
34. Smith,K., Li,Y., Piccinini,F., Csucs,G., Balazs,C., Bevilacqua,A. and
Horvath,P. (2015) CIDRE: an illumination-correction method for
optical microscopy. Nat. Methods, 12, 404–406.
35. Ritz,C., Baty,F., Streibig,J.C. and Gerhard,D. (2015) Dose-Response
analysis using R. PLoS One, 10, e0146021.
36. Meier,R., Franceschini,A., Horvath,P., Tetard,M., Mancini,R., von
Mering,C., Helenius,A. and Lozach,P.Y. (2014) Genome-wide small
interfering RNA screens reveal VAMP3 as a novel host factor
required for Uukuniemi virus late penetration. J. Virol., 88,
8565–8578.
37. Jackson,A.L. and Linsley,P.S. (2010) Recognizing and avoiding
siRNA off-target effects for target identification and therapeutic
application. Nat. Rev. Drug Discov, 9, 57–67.
38. Angart,P.A., Carlson,R.J., Adu-Berchie,K. and Walton,S.P. (2016)
Terminal duplex stability and nucleotide identity differentially control
siRNA loading and activity in RNA interference. Nucleic Acid Ther.,
26, 309–317.
39. Reynolds,A., Leake,D., Boese,Q., Scaringe,S., Marshall,W.S. and
Khvorova,A. (2004) Rational siRNA design for RNA interference.
Nat. Biotechnol., 22, 326–330.
40. Petri,S. and Meister,G. (2013) siRNA design principles and off-target
effects.Methods Mol. Biol., 986, 59–71.
41. Liu,J., Carmell,M.A., Rivas,F.V., Marsden,C.G., Thomson,J.M.,
Song,J.J., Hammond,S.M., Joshua-Tor,L. and Hannon,G.J. (2004)
Argonaute2 is the catalytic engine of mammalian RNAi. Science,
305, 1437–1441.
42. Hannus,M., Beitzinger,M., Engelmann,J.C., Weickert,M.T.,
Spang,R., Hannus,S. and Meister,G. (2014) siPools: highly complex
but accurately defined siRNA pools eliminate off-target effects.
Nucleic Acids Res., 42, 8049–8061.
43. Kittler,R., Surendranath,V., Heninger,A.K., Slabicki,M., Theis,M.,
Putz,G., Franke,K., Caldarelli,A., Grabner,H., Kozak,K. et al.
(2007) Genome-wide resources of endoribonuclease-prepared short
interfering RNAs for specific loss-of-function studies. Nat. Methods,
4, 337–344.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky798/5095462 by W
W
Z Bibliothek (O
effentliche Bibliothek der U
niversitÃ¤t Basel) user on 08 O
ctober 2018
